Table of Contents
Overview
Definition and Scope
Statistical genetics is defined as the scientific discipline that focuses on the development and application of analytical methods to derive inferences from genetic data, particularly in the context of human genetics.[2.1] This field has emerged in response to the innovations in genetic methodologies, which have resulted in the generation of large amounts of data that require robust statistical and computational methods for accurate processing.[3.1] The primary aim of research in statistical genetics is to develop theory and methodology that can support the interpretation of genetic studies, addressing commonly encountered issues rather than providing an exhaustive overview of the field.[4.1] A crucial concept within statistical genetics is heritability, which is quantitatively defined as the proportion of phenotypic variance in a trait that can be attributed to genetic variance.[15.1] Heritability estimates can range from 0 to 1, with values closer to 1 indicating a high degree of heritability for a trait within a population.[17.1] It is important to note that heritability should not be interpreted as a measure of individual risk; rather, it reflects the variability of a trait in a population due to genetic differences.[18.1] Heritability is estimated through various methods, including comparisons of phenotypic variation among related individuals and analyses of genotype-phenotype associations.[16.1] However, the interpretation of heritability can be complex, especially for multifactorial traits, as it is influenced by environmental factors and the interactions between genes and the environment.[18.1]Importance in Genetics Research
Statistical genetics plays a crucial role in understanding the genetic basis of traits and diseases, particularly through the concept of heritability. Heritability allows researchers to compare the relative contributions of genetic and environmental factors to the variation of traits within and across populations, making it a fundamental concept in quantitative genetics, selective breeding, and behavior genetics, such as in twin studies.[20.1] Moreover, the integration of statistical genetics with traditional epidemiological methods enhances our understanding of complex diseases. This synergy allows for the localization of genes influencing disease susceptibility and the examination of genetic effects on health outcomes. For instance, the Program in Genetic Epidemiology and Statistical Genetics emphasizes the genetic dissection of complex human diseases, particularly focusing on cancer, to improve diagnostic and prognostic capabilities.[22.1] Statistical methods developed for causal inference in genetic epidemiology also contribute to advancing methodologies in the field. By limiting confounding factors associated with genetic associations, these methods enable more precise measurements of genetic influences, thereby enhancing the reliability of findings in genetic research.[23.1] The rapid production of genomic data has outpaced the ability to analyze and interpret it meaningfully, resulting in questionable applications of statistical models in genetics research.[14.1] To address these challenges, it is essential to implement robust data protection regulations that safeguard patient information and enhance ethical standards.[9.1] Furthermore, the integration of genomics into personalized medicine has the potential to significantly improve treatment precision, particularly in fields such as oncology and pharmacogenomics. However, realizing this potential requires overcoming obstacles related to cost, accessibility, and clinical integration.[9.1] In light of these issues, the authors of the Consensus View provide recommendations for best practices in population genomic data analysis, emphasizing the need for further attention to statistical inference and theory.[14.1]History
Key Milestones in Statistical Genetics
The field of statistical genetics has evolved significantly, with key milestones that have shaped its development. A foundational moment in this field was the work of Gregor Mendel, a 19th-century Moravian friar, whose famous experiments established universal laws that underpin modern genetics. Mendel's principles, known as Mendelian inheritance, describe how characteristics are passed from one generation to the next and hold a status in biology comparable to that of Newtonian mechanics in physics.[56.1] His first key principle, the Law of Segregation, states that each organism carries two alleles for each trait, one inherited from each parent. During the formation of gametes, these alleles separate, ensuring that each gamete contains only one allele for each trait, which explains the inheritance of genetic factors from parents to offspring and promotes genetic diversity.[55.1] Furthermore, Mendel employed statistical methods to construct his model of inheritance, highlighting the importance of mathematics in understanding genetic principles.[53.1] The integration of Mendelian genetics with Darwinian natural selection marked the beginning of the modern evolutionary synthesis, a critical development in the field. This synthesis was significantly advanced by the work of Ronald Fisher, who introduced statistical methods that allowed for the analysis of genetic data in the context of evolutionary theory.[52.1] Fisher's contributions, alongside the development of population genetics, provided a statistical framework that brought genetic explanations into the study of evolution.[50.1] In the latter half of the 20th century, the field experienced a remarkable research impetus driven by breakthroughs in molecular genetics and the advent of automated data-recording devices. The introduction of computer-intensive statistical methods, particularly the bootstrap and Markov chain Monte Carlo (MCMC) techniques, revolutionized the analysis of genetic data, enabling researchers to handle increasingly complex datasets.[51.1] This period also saw the rise of genome-wide association studies (GWAS), which utilized statistical models to identify genetic variants associated with diseases, further solidifying the role of statistical genetics in understanding human health.[49.1] As the 21st century progressed, advancements in computational techniques, such as high-performance computing (HPC) and machine learning, have significantly influenced the ability to analyze large-scale genomic data. These innovations have facilitated the identification of clinically actionable genetic variants and have enhanced our understanding of genetic variation and disease susceptibility.[65.1] The demand for innovative statistical computing methodologies continues to grow, reflecting the ongoing evolution of statistical genetics in response to the complexities of modern genomic data.[73.1]Evolution of Statistical Methods
The evolution of statistical methods in genetics has been significantly influenced by advancements in technology and computational power, leading to a deeper understanding of genetic variation and complex diseases. The field of statistical genetics has rapidly transformed, particularly with the integration of multi-omics data, which encompasses genetics, genomics, proteomics, and metabolomics. This evolution has facilitated the development of precision medicine tools and enhanced our comprehension of biological processes.[59.1] Recent methodological advancements have focused on addressing the challenges posed by high-throughput genomic data, particularly in genetic association studies. These studies have employed various statistical methods, ranging from single-marker tests to more complex multi-marker data mining techniques, which are essential for detecting gene-gene interactions.[61.1] The introduction of the ancestral recombination graph (ARG) has also provided a framework for estimating recombination rates, demographic models, and the influence of selection on alleles, thereby enriching our understanding of population genetics.[62.1] The integration of Bayesian methods into statistical genetics has marked a significant shift in data analysis approaches. Bayesian techniques offer advantages over traditional frequentist methods, particularly in handling complex models and incorporating prior information. This hybridization of Bayesian and frequentist approaches has emerged as a powerful strategy, allowing researchers to leverage the strengths of both methodologies.[79.1] Despite the continued dominance of frequentist measures such as p-values and confidence intervals, Bayesian methods have gained traction, particularly in the context of big data and machine learning applications in genetics.[81.1] The evolution of statistical methods in genetics has been significantly influenced by rapid advancements in computational power and data collection techniques. These methodological advances in statistical and computational genomics have enabled researchers to better identify and interpret both rare and common variants responsible for complex human diseases.[67.1] Furthermore, human genetic research has expanded its relevance beyond traditional fields such as biology and medicine, now encompassing applications in psychology, psychiatry, statistics, demography, sociology, and economics.[68.1] This integration of large-scale molecular genetic information into diverse research areas has been made possible by the availability of advanced computing power and innovative techniques.[68.1] Additionally, computational biology has made powerful strides, uncovering trends in human health through the integration of heterogeneous 'big data' and facilitating the identification and classification of disease-associated genes.[72.1] As the field continues to develop, there is a growing focus on creating sophisticated statistical, computational, and machine/deep learning algorithms to analyze large-scale multi-omic and health data, which will further enhance our understanding of the genetics of complex diseases.[71.1]Recent Advancements
Innovations in Statistical Techniques
Recent advancements in statistical genetics have introduced innovative methodologies that significantly enhance the analysis of genetic data, particularly in human genetics.[2.1] The growing volume of genetic data demands sophisticated statistical and computational methods for effective processing and analysis.[3.1] A notable innovation is the development of advanced statistical models that utilize computational power to predict complex traits and diseases. Genome-wide association studies (GWAS) have been instrumental in identifying genetic variants, which can be aggregated into predictions across various traits, facilitating precision medicine through polygenic risk scores.[111.1] These models address challenges such as multiple testing adjustments and managing large datasets common in high-throughput SNP genotyping.[112.1] Significant progress in statistical methodologies has improved our understanding of gene-environment interactions (G × E), crucial for elucidating complex human traits and diseases.[115.1] The rise of large population biobanks has spurred the development of statistical methods to identify these interactions.[113.1] Recognized for their role in enhancing genetic discovery, G × E interactions help address issues like missing heritability and population heterogeneity, supporting precision medicine.[116.1] Innovative approaches have been introduced to estimate the phenotypic variance explained by G × E interactions, particularly using GWAS summary statistics for biobank-scale data.[115.1] These advancements clarify the interplay between genetic variation and environmental factors, furthering the pursuit of precision medicine.[116.1] Moreover, the development of Polygenic Risk Score (PRS)-based methods has gained momentum, with new frameworks enhancing genomic prediction capabilities by incorporating a broader range of genetic variants and employing sophisticated statistical techniques to improve prediction accuracy.[127.1]Applications in Genetic Epidemiology
Recent advancements in statistical genetics have significantly enhanced applications in genetic epidemiology, particularly in identifying genetic risk factors for complex diseases. These advancements have enabled researchers to establish statistical associations between genetic polymorphisms and various phenotypes or disease states, thereby facilitating the identification of genetic risk factors that can be further explored through traditional epidemiological methods.[105.1] For instance, genome-wide association studies (GWAS) have emerged as a powerful tool in this domain, allowing for the detection of genetic variants associated with diseases such as cancer, which can lead to earlier detection and the development of preventative strategies.[104.1] Moreover, the integration of machine learning and artificial intelligence into genetic data analysis has improved the accuracy and efficiency of identifying these associations. AI-driven approaches enhance the integration of genomic and transcriptomic data, allowing researchers to uncover previously undetectable patterns that can inform diagnostics and personalized medicine.[96.1] For example, a study utilizing machine learning algorithms demonstrated significant differences in immune responses to viruses based on genetic variations, highlighting the potential of these techniques in reconstructing gene co-expression networks and understanding disease mechanisms.[97.1] The ongoing evolution of genomic medicine, particularly within healthcare systems like the NHS, emphasizes the importance of integrating genetic testing into routine practice. This integration is expected to revolutionize healthcare by providing prompt and accurate diagnoses, risk stratification based on genotype, and personalized treatment options.[102.1] As the field progresses, the focus on statistical genetics will likely continue to shift towards patient-centered care, enhancing the overall effectiveness of medical interventions and reducing adverse drug reactions.[103.1]In this section:
Methodologies
Statistical Models in Genetics
Statistical genetics encompasses a variety of methodologies aimed at understanding genetic data and its implications for health and disease. One of the foundational aspects of this field is the development and application of statistical models that can analyze genetic variation and its association with phenotypic traits. These models are crucial for deriving inferences from genetic data, particularly when phenotype and genotype data are collected from a sufficient number of individuals affected by genetic disorders.[133.1] A significant focus within statistical genetics is on population-based association mapping, which employs various statistical methods to identify genetic contributors to diseases. This includes single-marker tests of association, which assess the relationship between individual genetic markers and traits, as well as multi-marker data mining techniques that explore interactions between multiple genetic variants.[131.1] The choice of an appropriate single-marker association test is critical for the success of case-control studies, as these tests must demonstrate robust performance across diverse disease risk models.[147.1] Statistical models play a crucial role in genetics, particularly in the context of genetic linkage and association studies. These methodologies have been widely adopted in the investigation of human complex traits and diseases, leading to significant advancements in the field. For example, genome-wide association studies (GWAS) have emerged as a prominent tool for quantifying and partitioning trait heritability, fine-mapping functional variants, and predicting genetic risks for various phenotypes.[152.1] Furthermore, advances in technology, statistical methods, and the increasing scale of research efforts have provided valuable insights into the processes that have shaped current patterns of genetic variation. This has resulted in the creation of extensive maps of genetic associations with human traits and diseases, facilitating the characterization of their genetic architecture.[150.1] The evolution of statistical methodologies in genetic epidemiology has also led to the identification of complex disease traits, with advancements in computational power and statistical techniques facilitating new insights into genetic variation.[149.1] As the field continues to grow, the incorporation of genetic data into clinical practice is becoming increasingly essential for developing personalized treatment plans and improving patient outcomes.[154.1] This integration underscores the importance of statistical models in translating genetic findings into actionable clinical strategies.Data Analysis Techniques
Data analysis techniques in statistical genetics have evolved significantly with the integration of machine learning and bioinformatics approaches. These methodologies facilitate the analysis of genomic data, enabling personalized medicine through improved disease risk prediction and drug response analysis. Various machine learning techniques, including classification, regression, and deep learning, are employed to analyze genomic data, such as variant calling and disease risk prediction, thereby enhancing the precision of genetic analyses.[138.1] One of the critical challenges in applying machine learning to genetic data is the issue of imbalanced datasets, which can affect model performance. Studies have systematically explored the impact of data preprocessing techniques, feature selection methods, and model choices on the efficacy of machine learning models trained on such imbalanced genetic data.[139.1] Furthermore, machine learning can utilize diverse genomic assay data, including microarray, RNA-seq, and chromatin accessibility assays, to improve the robustness of genetic analyses.[140.1] As new technologies emerge, there is an increasing demand for innovative machine learning methods and experts capable of adapting these techniques to large and complex datasets.[140.1] In genetic association studies, single-marker tests (SMTs) are typically employed for analyzing common and low-frequency single nucleotide variants (SNVs) with a minor allele frequency (MAF) greater than 0.01 or 0.005. In contrast, multi-marker tests (MMTs) have gained significant attention for their effectiveness in analyzing rare SNVs.[142.1] The performance of two-marker tests, a specific type of MMT, can be superior to that of SMTs when the correlation between adjacent markers is high. However, under certain conditions, such as those presented by HapMap data, two-marker tests may exhibit reduced power compared to SMTs due to limitations on the number of possible haplotypes.[143.1] While the majority of genome-wide association studies (GWAS) still rely on single-marker association methods, MMTs allow for the simultaneous testing of all or subsets of markers, which can enhance the detection of causal gene regions compared to traditional single-marker methods.[144.1] Furthermore, the excess of significant markers (ESM) test, a permutation-based regional association test, has been shown to possess greater power for detecting causal gene regions in typical GWAS data than single-marker methods and many popular region-based tests.[145.1] Population-based association studies have become increasingly important in mapping genes associated with complex diseases. These studies benefit from greater efficiency in sample recruitment and increased power compared to family-based studies. However, they also face challenges, such as the risk of false positives due to population stratification if not properly accounted for.[157.1] The advantages of utilizing broader genetic variations from natural populations over traditional quantitative trait locus (QTL) mapping in biparental crosses further underscore the importance of these methodologies.[158.1] Advancements in bioinformatics and data mining techniques have significantly influenced the landscape of population-based association mapping. These developments are facilitated by the successful linking of population-based administrative and other datasets, which are made available for research under strong confidentiality protections.[159.1] In the era of big data, the medical community is increasingly focused on maximizing the utilization and processing of rapidly expanding medical datasets for clinical-related and policy-driven research. This necessitates the creation of medical databases that can be aggregated, interpreted, and integrated at both individual and population levels.[160.1]In this section:
Applications
Role in Disease Association Studies
Statistical genetics plays a crucial role in disease association studies by providing methodologies to analyze genetic data and identify potential genetic risk factors for complex diseases. One of the primary applications is the use of polygenic risk scores (PRS), which have emerged as a promising tool for predicting disease risk and treatment outcomes based on genomic data. These scores are developed from thousands of genome-wide association studies (GWAS), predominantly involving populations of European ancestry, although their applicability in non-European populations remains a concern due to insufficient evaluation.[190.1] In recent years, Bayesian methods have gained traction in genetic association studies, particularly within the framework of genome-wide association studies (GWAS).[181.1] These methods offer several advantages over traditional frequentist approaches, including the ability to compute measures of evidence that can be directly compared among single nucleotide polymorphisms (SNPs) across different studies.[179.1] Furthermore, Bayesian analyses provide a rational and quantitative framework for incorporating biological information, allowing for the evaluation of a range of possible genetic models in a single analysis.[179.1] Additionally, Bayesian approaches can be easier to interpret and have been employed in various genetic domains, such as the classification of genotypes, estimating relationships, population genetics, molecular evolution, linkage mapping, and quantitative genetics.[180.1] The design and analysis of population-based case-control studies are crucial for investigating genetic risk factors associated with complex diseases. These studies highlight specific considerations relevant to genetic research, such as the necessity for family-based designs and the differentiation between correlation and causation.[189.1] A recent advancement in this field is the introduction of a latent causal variable (LCV) model, which effectively distinguishes between genetic correlation and causation.[192.1] This model has been applied to genome-wide association summary statistics, enhancing our understanding of the relationships between genetic factors and various traits.[192.1]Impact on Public Health and Policy
The integration of statistical genetics into public health and policy is set to transform personalized medicine by enhancing patient outcomes and healthcare delivery. By leveraging genetic data, healthcare providers can develop individualized treatment strategies tailored to patients' unique genetic profiles, thereby advancing healthcare innovations and improving clinical practices.[183.1] The mainstreaming of genetic testing, including whole genome sequencing within healthcare systems like the NHS, highlights the growing importance of genomics in clinical settings. This shift promises to revolutionize healthcare, particularly for individuals with rare diseases or cancer, by enabling precise diagnoses and personalized treatment options.[185.1][185.1] Ethical considerations are paramount in the integration of genetics into personalized medicine. Issues such as genetic discrimination, privacy, informed consent, and equitable resource distribution must be addressed to ensure responsible implementation. Collaboration among researchers, healthcare providers, policymakers, and ethicists is essential to navigate these challenges, safeguarding patient privacy and promoting equitable access to personalized medicine resources.[184.1][184.1] As statistical genetics continues to evolve, its role in analyzing genetic data will enhance our understanding of complex traits and improve healthcare delivery. This approach contrasts with traditional 'one-size-fits-all' methods, emphasizing the importance of tailoring healthcare strategies to individual genetic profiles. The focus on statistical genetics will likely continue to shift towards patient-centered care, enhancing the overall effectiveness of medical interventions and reducing adverse drug reactions.[186.1][186.1]Challenges And Future Directions
Current Limitations in Statistical Genetics
The problem of 'missing heritability' presents significant challenges in the field of statistical genetics, affecting both common and rare diseases. This phenomenon refers to the discrepancy between heritability estimates derived from genotype data and those obtained from twin studies, which has been a topic of debate for over a decade.[239.1] Despite advancements in technology, such as genome-wide association studies (GWAS), which have identified numerous susceptibility loci for complex diseases, these loci account for only a limited proportion of the total heritability.[238.1] Consequently, the 'missing heritability' issue hinders the discovery, diagnosis, and patient care associated with these diseases.[237.1] The issue of 'missing heritability' has predominantly been associated with common and complex diseases; however, rare diseases also encounter similar challenges despite advancements in technology.[234.1] Heritability is defined as the fraction of phenotypic variability in a population that can be attributed to genetic factors, reflecting the tendency for offspring to resemble their parents in phenotype.[235.1] The problem of missing heritability necessitates urgent consideration in various complex conditions, as it raises significant public health concerns, particularly regarding the implications of heritable epigenetic marks that can be transmitted across generations.[236.1] As the complexities of heritable traits are explored, it is essential to address the problem of missing heritability, which requires urgent consideration in many complex conditions.[236.1] Furthermore, the public health implications of heritable epigenetic marks that are passed through multiple generations represent a significant concern that must be effectively communicated to both researchers and the general public.[236.1] Addressing these issues is critical for enhancing our understanding of genetic epidemiology and its impact on public health initiatives.[236.1]Emerging Trends and Research Opportunities
One of the fundamental challenges in statistical genetics is managing the vast amounts of data generated by modern genomic technologies, particularly high-dimensional data from sequencing studies. This complexity necessitates the development of efficient methodologies to identify disease-predisposing genes, as well as to conduct quality control and statistical data analysis.[209.1] Furthermore, these manifold challenges can only be effectively addressed through interdisciplinary collaboration, which encourages research and training at the interface between human genetics and the mathematical sciences.[213.1] Programs such as the Interdisciplinary Training Program in Statistical Genetics/Genomics and Computational Biology aim to cultivate the next generation of quantitative genomic scientists, emphasizing the importance of a strong understanding of cutting-edge methodologies.[214.1] Moreover, the limitations of current approaches, such as Genome-Wide Association Studies (GWAS), have led to the recognition of the "missing heritability" problem, where discovered genetic variants account for only a small proportion of the heritability of complex traits.[212.1] This has prompted researchers to explore alternative strategies, including Genome-Wide Interaction Studies, which aim to address these gaps by investigating interactions among genetic variants.[216.1] The integration of machine learning techniques into genome-wide association studies (GWAS) is emerging as a promising approach to enhance our understanding of complex traits and diseases. Machine learning algorithms are particularly adept at detecting and characterizing high-order interactions among multiple genetic variants, which traditional methods may overlook.[221.1] These advanced algorithms not only facilitate the identification of significant single nucleotide polymorphisms (SNPs) but also improve disease risk assessment and prediction.[220.1] However, the challenge of missing heritability remains a significant issue, as GWAS have been critiqued for their inability to fully explain the genetic basis of complex diseases through single-locus main effects.[219.1] To address this, there is a need to explore the contributions of rare variants, non-coding regions, and structural variations, while also revisiting heritability estimates.[219.1] The application of machine learning in this context holds the potential to predict novel susceptibility loci for complex diseases by interpreting regulatory features alongside published GWAS results.[218.1] Looking ahead, the integration of statistical genetics into routine clinical practice is expected to evolve significantly. The introduction of clinical genome and exome sequencing (CGES) is already transforming the landscape for clinical geneticists, with many institutions investing in the necessary infrastructure and technology.[222.1] Additionally, pharmacogenomic tests are gaining traction, providing insights that can help predict and prevent adverse drug reactions, thereby improving patient outcomes.[223.1] As these trends continue, ethical considerations will also play a crucial role in shaping the future of statistical genetics in clinical settings.In this section:
References
[2] Statistical genetics - Wikipedia — Statistical genetics is a scientific field concerned with the development and application of statistical methods for drawing inferences from genetic data. The term is most commonly used in the context of human genetics. Research in statistical genetics generally involves developing theory or methodology to support research in one of three
[3] Statistical and Computational Methods for Genetic Diseases: An Overview ... — Innovation of genetic methodologies leads to the production of large amounts of data that needs the support of statistical and computational methods to be correctly processed. The aim of the paper is to provide an overview of statistical and computational methods paying attention to methods for the sequence analysis and complex diseases. 1.
[4] Statistical genetics with application to population-based study design ... — In this review, key concepts in statistical genetics will be explained. The goal is to discuss commonly encountered issues in the interpretation of genetic studies rather than provide an in-depth overview of the rapidly expanding field of statistical genetics. Specifically, we will outline the most common study designs, procedures for quality
[9] PDF — Strengthen Data Privacy and Ethical Standards Robust data protection regulations should be i m p l e m e n t e d t o safeguard patientThe findings from this analysis indicate that while genomics has the potential to revolutionize personalized medicine, several key factors must be addressed to fully integrate it into routine healthcare: Genomics Enhances Treatment Precision The use of genomics in personalized medicine significantly enhances the precision of treatment, leading to better patient outcomes, particularly in oncology, pharmacogenomics, and the management of rare diseases. However, the full potential of genomics in personalized medicine can only be realized by addressing the challenges of cost, accessibility, data privacy, ethical considerations, clinical integration, and regulatory issues.
[14] Recommendations for improving statistical inference in ... - PLOS — Genomic data are now being produced at a far greater rate than they can be meaningfully analyzed and interpreted, leading to some questionable use of statistical models. In this Consensus View, the authors provide recommendations for current best practices in population genomic data analysis and highlight areas of statistical inference and theory that are in need of further attention.
[15] 5.2: Heritability - Biology LibreTexts — Statistical Basis for Understanding Heritability. From a quantitative standpoint, heritability is defined as the proportion of the phenotypic variance that is explained by genetic variance.Variation in phenotypic variance \( \sigma^{2}_{p} \) is the sum of variation due to genetic factors (genotypic variance, \( \sigma^{2}_{g} \) ) and variation due to environmental factors (environmental
[16] Heritability - Wikipedia — Heritability is estimated by comparing individual phenotypic variation among related individuals in a population, by examining the association between individual phenotype and genotype data, or even by modeling summary-level data from genome-wide association studies (GWAS). Heritability is an important concept in quantitative genetics, particularly in selective breeding and behavior genetics (for instance, twin studies). For this reason, David Moore and David Shenk describe the term "heritability" in the context of behavior genetics as "...one of the most misleading in the history of science" and argue that it has no value except in very rare cases. When studying complex human traits, it is impossible to use heritability analysis to determine the relative contributions of genes and environment, as such traits result from multiple causes interacting. In particular, Feldman and Lewontin emphasize that heritability is itself a function of environmental variation. However, some researchers argue that it is possible to disentangle the two.
[17] Definition of heritability - NCI Dictionary of Genetics Terms — The proportion of variation in a population trait that can be attributed to inherited genetic factors. Heritability estimates range from 0 to 1 and are often expressed as a percentage. A number close to 1 may be indicative of a highly heritable trait within a population. It should not be used to estimate risk on an individual basis.
[18] What is heritability?: MedlinePlus Genetics — What is heritability?: MedlinePlus Genetics URL of this page: https://medlineplus.gov/genetics/understanding/inheritance/heritability/ A heritability close to zero indicates that almost all of the variability in a trait among people is due to environmental factors, with very little influence from genetic differences. A heritability close to one indicates that almost all of the variability in a trait comes from genetic differences, with very little contribution from environmental factors. Most complex traits in people, such as intelligence and multifactorial diseases, have a heritability somewhere in the middle, suggesting that their variability is due to a combination of genetic and environmental factors. So, a heritability of 0.7 does not mean that a trait is 70% caused by genetic factors; it means that 70% of the variability in the trait in a population is due to genetic differences among people.
[20] Heritability in the genomics era — concepts and misconceptions — Heritability allows a comparison of the relative importance of genes and environment to the variation of traits within and across populations. The concept of heritability and its definition as an
[22] Program in Genetic Epidemiology and Statistical Genetics — The Program in Genetic Epidemiology and Statistical Genetics (PGSG)- formerly the Program in Molecular and Genetic Epidemiology- focuses on the genetic dissection of complex human diseases. The Program gives special emphasis to deciphering the molecular mechanisms underlying cancer to improve our capacities for cancer diagnosis, prognosis and
[23] Modern Epidemiologic Approaches to Interaction: Applications to the ... — Statistical methods were developed to aid in causal inference. ... Likewise, the integration of genetic thinking into epidemiology can advance methodology. ... One advantage of genetic epidemiology is that the confounders of genetic associations are limited, and the more carefully specified and measured the genetic factor, the more limited the
[49] The Fundamentals of Modern Statistical Genetics | SpringerLink — This book covers the statistical models and methods that are used to understand human genetics, following the historical and recent developments of human genetics. Starting with Mendel's first experiments to genome-wide association studies, the book describes how genetic information can be incorporated into statistical models to discover disease genes. All commonly used approaches in
[50] History_of_genetics - bionity.com — Alongside experimental work, mathematicians developed the statistical framework of population genetics, bring genetical explanations into the study of evolution. With the basic patterns of genetic inheritance established, many biologists turned to investigations of the physical nature of the gene.
[51] Developments in statistical analysis in quantitative genetics — A remarkable research impetus has taken place in statistical genetics since the last World Conference. This has been stimulated by breakthroughs in molecular genetics, automated data-recording devices and computer-intensive statistical methods. The latter were revolutionized by the bootstrap and by Markov chain Monte Carlo (McMC). In this overview a number of specific areas are chosen to
[52] Special issues on advances in quantitative genetics: introduction — This fusion of Mendelian genetics with Darwinian natural selection was the start of the modern evolutionary synthesis. Fisher's paper also marked a critical point in modern statistics, and this synergism between the development of new statistical methods and the ever-increasing complexity of genetic/genomic data sets continues to this day.
[53] 12.1 Mendel's Experiments and the Laws of Probability — In other words, Mendel used statistical methods to build his model of inheritance. As you have likely noticed, the AP Biology course emphasizes the application of mathematics. Two rules of probability can be used to find the expected proportions of different traits in offspring from different crosses.
[55] Mendel's Laws of Inheritance - Mendelian Inheritance — Mendel's first key principle is the Law of Segregation, which states that each organism carries two alleles for each trait, one from each parent. These alleles separate during the formation of gametes (sperm or egg cells), so each gamete contains only one allele for each trait. This explains why offspring inherit one genetic factor from each parent, ensuring genetic diversity.
[56] Factcheck study shows that Mendel's statistics add up — The famous experiments of the 19th century Moravian friar Gregor Mendel set down universal laws that still underpin the field of genetics. The term Mendelian inheritance, describes how characteristics are passed from one generation to the next, and in biology has a status like Newtonian mechanics in physics.
[59] Modeling Complex Data | Yale School of Public Health — In recent years, a few areas have been a focus of advanced modeling efforts. Statistical genetics has evolved into multi-omics, a field including data on genetics, genomics, proteomics and metabolomics. Methodological and data science advances in the field have enabled precision medicine tools and a deeper understanding of biological processes.
[61] Statistical methods in genetics | Briefings in Bioinformatics | Oxford ... — This review provides a concise account of a number of selected statistical methods for population-based association mapping, from single-marker tests of association to multi-marker data mining techniques for gene–gene interaction detection. In this work, under the alternative hypothesis of unequal marker allele frequencies between cases and controls, the asymptotic distribution of the chi-squared test is expressed as a function of _G_2, a genetic distance measure, which depends on the population history; using a simple deterministic population genetic model accounting for a single mutation and ignoring genetic drift, the value of _G_2 can be computed and the power of the test obtained under various disease models and population histories.
[62] From summary statistics to gene trees: Methods for inferring positive ... — In addition to representing the explicit evolutionary history across a set of DNA sequences, the ARG is useful in addressing a wide variety of biological questions, including: (i) estimation of the recombination rate, (ii) estimation of demographic model , including divergence times, effective population sizes, and gene flow, (iii) estimation of allele ages, based on mapping of mutation events to branches of the ARG, and (iv) characterization of the influence of selection on each allele, based on departures from the patterns of coalescence and recombination expected under neutrality [5,97-99]. Much work studying the genetics of speciation involves identifying loci having unusually high levels of population differentiation, as measured by Fst. ARG-based measures provide an alternative and complementary way to infer selective sweeps where such observations would not be possible using only simple summary statistics such as Fst, π or Tajima’s D.
[65] Big Data in Genomics: Overcoming Challenges Through High-Performance ... — Wang L.T., and Wang H.M., 2024, Big data in genomics: overcoming challenges through high-performance computing, Computational Molecular Biology, 14(4): 155-162 (doi: 10.5376/cmb.2024.14.0018) High performance computing (HPC) technology aims to address key issues in genomics big data analysis. Regarding the current status of big data in genomics and the crucial role of high-performance computing in overcoming related challenges, we will explore various computational methods and tools developed for managing and analyzing large genomic datasets, with a focus on their success and ongoing challenges. High-performance computing (HPC) plays a crucial role in personalized medicine and genomic diagnostics by enabling the analysis of large-scale genomic data to identify clinically actionable genetic variants.
[67] Computational Genomics in the Era of Precision Medicine: Applications ... — Rapid methodological advances in statistical and computational genomics have enabled researchers to better identify and interpret both rare and common variants responsible for complex human diseases. As we continue to see an expansion of these
[68] Home | Intro to Stats Gen — Human genetic research is now relevant beyond biology, epidemiology, and the medical sciences, with applications in such fields as psychology, psychiatry, statistics, demography, sociology, and economics. With advances in computing power, the availability of data, and new techniques, it is now possible to integrate large-scale molecular genetic information into research across a broad range of
[71] Computational Biology in Genomic Research - Icahn School of Medicine — Some of the key research areas within computational biology in our department include developing statistical, computational, and machine/deep learning algorithms/software, analyzing large-scale multi-omic and health data, studying the genetics of complex diseases, and using computational methods to study gene/protein regulation in development
[72] Computational Structural Biology: Successes, Future Directions, and ... — Computational biology has made powerful advances. Among these, trends in human health have been uncovered through heterogeneous 'big data' integration, and disease-associated genes were identified and classified. Along a different front, the dynamic
[73] Genes | Special Issue : Advanced Statistical Computing in Medical ... — To make sense of these data, there is an increasing demand for innovative statistical computing methodologies. This Special Issue will focus on advancements in statistical computing within the context of understanding complex phenotypes. We aim to showcase research that leverages novel or alternative computational strategies.
[79] Bayesian Frequentist hybrid Model wth Application to the Analysis of ... — In an attempt to take full advantages of both approaches, we develop a Bayesian-frequentist hybrid approach, in which a subset of the model parameters is inferred by the Bayesian method, while the rest parameters by the frequentist's. This new hybrid approach provides advantages over those of the Bayesian or frequentist's method used alone.
[81] PDF — Frequentist measures like p-values and confidence intervals continue to dominate research, especially in the life sciences. However, in the current era of powerful computers and big data, Bayesian methods have undergone an enormous renaissance in fields like ma chine learning and genetics. There are now a number of large, ongoing clinical trials using Bayesian protocols, something that would
[96] GeneAI Innovations for Combined Genomic and Transcriptomic Data — Explore how AI-driven approaches enhance the integration of genomic and transcriptomic data, improving gene function prediction and genetic data analysis. By integrating AI with genomic and transcriptomic data, researchers can uncover previously undetectable patterns, improving diagnostics, drug discovery, and personalized medicine. Machine learning models help bridge this gap by analyzing vast biological datasets to infer gene roles based on genomic, transcriptomic, and proteomic patterns. A study in PLOS Computational Biology demonstrated that transfer learning models improved gene function prediction accuracy in Zea mays (maize) by incorporating knowledge from better-characterized plant genomes. Integrating genomic and transcriptomic data provides a more comprehensive view of gene regulation, expression dynamics, and disease mechanisms. Genomic data reveals the static blueprint of an organism’s DNA, while transcriptomic data captures how genes are expressed under varying conditions.
[97] Computational Methods for the Analysis of Genomic Data and Biological ... — In this context, new computational methods and tools, such as machine learning approaches or gene expression analysis tools, could provide the solution to such issues. With this aim, the work used different datasets from mice, with and without the ablation of the gene Ly6E, to reconstruct computational gene co-expression networks, by using a machine learning-based algorithm called EnGNet. The authors carried out an integration of differential expression analyses and reconstructed network exploration, and significant differences in the immune response to the virus were observed in Ly6E compared to in wild-type animals. This article proposes an integrative computational approach based on an exploratory and single-sample gene-set enrichment analysis of transcriptome and proteome data, and then a correlation analysis of drug-screening data.
[102] The rise of the genome and personalised medicine - PMC — As set out in the Annual report of the Chief Medical Officer 2016: Generation Genome_1 and the recent NHS England board paper _Creating a genomic medicine service to lay the foundations to deliver personalised interventions and treatments,2 the increasing ‘mainstreaming’ of genetic testing into routine practice and plans to embed whole genome sequencing in the NHS mean that the profile and importance of genomics is on the rise for many clinicians. Every human genome contains around 3–5 million genetic variants compared with the reference sequence. Genomic medicine has the capacity to revolutionise the healthcare of an individual with a rare disease or cancer by offering prompt and accurate diagnosis, risk stratification based upon genotype and the capacity for personalised treatments.
[103] PDF — Lechleiter, Ph.D. former Chairman, President, and CEO, Eli Lilly and Company The Personalized Medicine Report 9 THE BENEFITS Personalized medicine benefits patients and the health system by: ⊲ Shifting the emphasis in medicine from reaction to prevention ⊲ Directing targeted therapy and reducing trial-and-error prescribing ⊲ Reducing the frequency and magnitude of adverse drug reactions ⊲ Using cell-based or gene therapy to replace or circumvent molecular pathways associated with disease ⊲ Revealing additional targeted uses for medicines and drug candidates ⊲ Increasing patient adherence to treatment ⊲ Reducing high-risk invasive testing procedures ⊲ Helping to shift physician-patient engagement toward patient-centered care ⊲ Helping to control the overall cost of health care The Opportunity 10 cholesterol.
[104] PDF — Identifying genetic risk factors can enable earlier detection and preventative strategies. This is particularly valuable for complex diseases like cancer ... # Case Studies: Real-World Examples of Statistical Genetic Success (Insert a case study here showcasing a successful application of statistical genetics. For example, a GWAS study that
[105] Genetic Association Studies | Circulation - AHA/ASA Journals — Traditional epidemiological studies focus on assessing the impact of specific risk factors on disease risk in populations. The goal of a genetic association study is to establish statistical associations between ≥1 genetic polymorphisms and phenotypes or disease states and thus to identify genetic risk factors that can later be studied in a more comprehensive manner using traditional
[111] Statistical models and computational tools for predicting complex ... — Statistical models and computational tools for predicting complex traits and diseases - PubMed The genetic variants from genome-wide association studies (GWAS), including variants well below GWAS significance, can be aggregated into highly significant predictions across a wide range of complex traits and diseases. Statistical genetics and polygenic risk score for precision medicine. doi: 10.1534/genetics.119.302019.
[112] Next Generation Statistical Genetics: Modeling, Penalization, and ... — These include: (a) lasso penalized regression and association mapping, (b) ethnic admixture estimation, (c) matrix completion for genotype and sequence data, (d) the fused lasso and copy number variation, (e) haplotyping, (f) estimation of relatedness, (g) variance components models, and (h) rare variant testing. The advent of high-throughput SNP genotyping focused statisticians’ attention on several challenges: (a) less stringent p-value adjustments for multiple testing, (b) a wild excess of predictors over outcomes, (c) quality control of massive data sets, (d) adjustment for potential confounders such as population substructure, and (f) ultra-fast computation of test statistics (Cantor et al. Meta-analysis has become a standard tool in statistical genetics because it borrows strength across studies (Cantor et al.
[113] Statistical methods for gene-environment interaction analysis — The emergence of large population biobanks has led to the development of numerous statistical methods aiming at identifying gene-environment interactions (G × E). In this review, we present state-of-the-art statistical methodologies for G × E analysis.
[115] Gene-environment interactions in human health - Nature — Gene–environment interactions in human health | Nature Reviews Genetics Gene–environment interactions (G × E), the interplay of genetic variation with environmental factors, have a pivotal impact on human complex traits and diseases. H. GxEsum: a novel approach to estimate the phenotypic variance explained by genome-wide G × E interaction based on GWAS summary statistics for biobank-scale data. J. Gene–environment interaction in genome-wide association studies. J. Exploiting gene–environment interaction to detect genetic associations. Genome-wide meta-analysis of joint tests for genetic and gene–environment interaction effects. Subset-based analysis using gene–environment interactions for discovery of genetic associations across multiple studies or phenotypes. P. Finding novel genes by testing G × E interactions in a genome-wide association study.
[116] Many roads to a gene-environment interaction - Cell Press — Gene-environment interactions (GxEs) are of increasing interest for improving genetic discovery, explaining missing heritability and population heterogeneity, and facilitating precision medicine. 1 In general, the term describes any departure from a model with pure main effects for genetic and environmental terms, implying differences in the estimated genetic effect depending on the
[127] Advancements and limitations in polygenic risk score methods for ... — This scoping review aims to identify and evaluate the landscape of Polygenic Risk Score (PRS)-based methods for genomic prediction from 2013 to 2023, highlighting their advancements, key concepts, and existing gaps in knowledge, research, and technology. Over the past decade, various PRS-based methods have emerged, each employing different statistical frameworks aimed at enhancing prediction
[131] Statistical methods in genetics - Oxford Academic — This review provides a concise account of a number of selected statistical methods for population-based association mapping, from single-marker tests of association to multi-marker data mining techniques for gene–gene interaction detection. In this work, under the alternative hypothesis of unequal marker allele frequencies between cases and controls, the asymptotic distribution of the chi-squared test is expressed as a function of _G_2, a genetic distance measure, which depends on the population history; using a simple deterministic population genetic model accounting for a single mutation and ignoring genetic drift, the value of _G_2 can be computed and the power of the test obtained under various disease models and population histories.
[133] Statistical Genetics - an overview | ScienceDirect Topics — 10.1 Introduction. Statistical genetics is the scientific discipline that focuses on the development and application of analytical methods to derive inferences from genetic data. When it is possible to collect phenotype and genotype data from a sufficient number of individuals who are affected by a suspected genetic disorder, a number of statistical approaches are amenable to quantifying the
[138] Bioinformatics and Machine Learning: Analyzing Genomic Data for ... — (PDF) Bioinformatics and Machine Learning: Analyzing Genomic Data for Personalized Medicine Bioinformatics and Machine Learning: Analyzing Genomic Data for Personalized Medicine In this paper, we explore the integration of bioinformatics and machine learning approaches to analyze genomic data for personalized medicine. We discuss various machine learning techniques, such as classification, regression, and deep learning, applied to genomic data analysis, including variant calling, disease risk prediction, and drug response prediction. Keywords: Bioinformatics, Machine Learning, Personalized Medicine, Genomic Data Analysis, [Show full abstract] Science in Health Informatics involves the integration of computational, statistical, and machine learning methods to analyze and interpret this data, facilitating evidencebased decision-making, personalized medicine, and improved patient outcomes.
[139] Comparative Analysis of Machine Learning Techniques for Imbalanced ... — Comparative Analysis of Machine Learning Techniques for Imbalanced Genetic Data | Annals of Data Science Comparative Analysis of Machine Learning Techniques for Imbalanced Genetic Data In this study, we systematically explored the impact of various data preprocessing techniques, feature selection methods, and model choices on the performance of machine learning models trained on imbalanced genetic data. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Comparative Analysis of Machine Learning Techniques for Imbalanced Genetic Data.
[140] Machine learning in genetics and genomics - PMC - PubMed Central (PMC) — In addition to learning to recognize patterns in DNA sequences, machine learning can take as input data generated by other genomic assays, such as microarray or RNA-seq expression data, chromatin accessibility assays such as DNase-seq, MNase-seq, and FAIRE, or histone modification, transcription factor (TF) binding ChIP-seq data, etc. Sections 3–5 describe strategies a researcher can use to guide a machine learning model, through prior knowledge, means of integrating heterogeneous data sets and feature selection. As new technologies for generating large genomic and proteomic data sets emerge, pushing beyond DNA sequencing to mass spectrometry, flow cytometry and high-resolution imaging methods, demand will increase not only for new machine learning methods but also for experts capable of applying and adapting them to big data sets.
[142] Comparison of single-marker and multi-marker tests in rare variant ... — While single-marker tests (SMTs) are often the method of choice for the analysis of common and low-frequency single nucleotide variants (SNVs) with a minor allele frequency (MAF) greater than 0.01 or 0.005, multi-marker tests (MMTs) have attracted much attention over the last years for the analysis of rare SNVs.
[143] Power of Single- vs. Multi-Marker Tests of Association - PMC — A two-marker test has relatively better performance than single-marker tests when the correlation of the two adjacent markers is high. However, using HapMap data, two-marker tests tended to have a greater chance of being less powerful than single-marker tests, due to constraints on the number of actual possible haplotypes in the HapMap data.
[144] Penalized multimarker vs. single-marker regression methods for genome ... — The data from genome-wide association studies (GWAS) in humans are still predominantly analyzed using single-marker association methods. As an alternative to single-marker analysis (SMA), all or subsets of markers can be tested simultaneously. This approach requires a form of penalized regression (P …
[145] Efficient Software for Multi-marker, Region-Based Analysis of GWAS Data — These latter authors further showed that, under this model, the excess of significant markers (ESM) test, a permutation-based regional association test, had more power to detect a causal gene region in typical GWAS data than single marker methods, and many popular region-based tests (Thornton et al. 2013), even for GWAS containing only common
[147] Robust Tests for Single-marker Analysis in Case-Control Genetic ... — Choosing an appropriate single-marker association test is critical to the success of case-control genetic association studies. An ideal single-marker analysis should have robust performance across a wide range of potential disease risk models. MAX was
[149] The Role of Statistical Genetics in Unravelling Complex Traits an — Conclusion The increasing availability of large-scale genetic and multiomics datasets, coupled with advancements in computational power and statistical methodologies, will likely lead to new insights into the genetic basis of complex traits and diseases.
[150] Genetic and molecular architecture of complex traits — Advances in technology, statistical methods, and the growing scale of research efforts have all provided many insights into the processes that have given rise to the current patterns of genetic variation. Vast maps of genetic associations with human traits and diseases have allowed characterization of their genetic architecture.
[152] Advances and challenges in quantitative delineation of the genetic ... — Background Genome-wide association studies (GWAS) have been widely adopted in studies of human complex traits and diseases. Results This review surveys areas of active research: quantifying and partitioning trait heritability, fine mapping functional variants and integrative analysis, genetic risk prediction of phenotypes, and the analysis of sequencing studies that have identified millions of
[154] Integrating genetic data into clinical practice — The incorporation of genetics into contemporary clinical practice is essential for facilitating personalised treatment plans and early diagnosis, and can lead to significantly better patient outcomes. This guide provides healthcare providers with a comprehensive overview of how to effectively integrate genetic data into clinical settings.
[157] Population-Based Association Studies | SpringerLink — Population-based association studies have been playing a major role in mapping genes affected complex diseases. The advantages of population based association studies include greater efficiency in sample recruitment and more power than family-based studies. However, population-based association mapping may lead to false positive findings if population stratification is not properly considered
[158] Application of Association Mapping to Understanding the Genetic ... — The advantages of population-based association study, utilizing a sample of individuals from the germplasm collections or a natural population, over traditional QTL-mapping in biparental crosses primarily are due to (1) availability of broader genetic variations with wider background for marker-trait correlations (i.e., many alleles evaluated
[159] Privacy, Governance and Public Acceptability in Population Data Linkage ... — Introduction For several years, Population Data Linkage initiatives around the world have been successfully linking population-based administrative and other datasets and making extracts available for research under strong confidentiality protections. This paper provides an overview of current approaches in a range of scenarios, then outlines current relevant trends and potential implications
[160] From Population Databases to Research and Informed Health ... - PubMed — Background: In the era of big data, the medical community is inspired to maximize the utilization and processing of the rapidly expanding medical datasets for clinical-related and policy-driven research. This requires a medical database that can be aggregated, interpreted, and integrated at both the individual and population levels.
[179] PDF — widespread use in future genetic association analyses. Bayesian methods compute measures of evidence that can be directly compared among SNPs within and across studies. In addition, they provide a rational and quan-titative way to incorporate biological information, and they can allow for a range of possible genetic models in a single analysis.
[180] Bayesian statistics in genetics: a guide for the uninitiated - Cell Press — In addition, Bayesian approaches can be easier to interpret and they have been employed in many genetic areas, including: the classification of genotypes and estimating relationships 1-3; population genetics and molecular evolution 4-17; linkage mapping (including gene ordering and human-risk analysis 18-33); and quantitative genetics
[181] Bayesian statistical methods for genetic association studies — Bayesian analyses are increasingly being used in genetics, particularly in the context of genome-wide association studies. This article provides a guide to using Bayesian analyses for assessing
[183] Impact of Genetics on Personalized Medicine — Understanding the impact of genetics on personalized medicine is essential for developing targeted therapies and advancing healthcare innovations. By integrating genetic data into clinical practice, healthcare providers can offer individualized treatment strategies that cater to the specific needs of their patients. Overview of Personalized
[184] (PDF) The Role of Genetics in Personalized Medicine: Advancements ... — (PDF) The Role of Genetics in Personalized Medicine: Advancements, Challenges, and Ethical Considerations The Role of Genetics in Personalized Medicine: Advancements, Challenges, and Ethical Considerations This article explores the advancements, challenges, and ethical considerations associated with the integration of genetics into personalized medicine. Ethical considerations, including genetic discrimination, privacy and confidentiality, informed consent, and equitable distribution of resources, are crucial in the implementation of personalized medicine. Collaboration among researchers, healthcare providers, policymakers, and ethicists is necessary to ensure the responsible and ethical use of genetic information, safeguard patient privacy, and promote equitable access to personalized medicine resources. By navigating these advancements, overcoming challenges, and addressing ethical considerations, personalized medicine can revolutionize healthcare, providing tailored and effective treatments for individuals based on their unique genetic characteristics.
[185] The rise of the genome and personalised medicine - PMC — As set out in the Annual report of the Chief Medical Officer 2016: Generation Genome_1 and the recent NHS England board paper _Creating a genomic medicine service to lay the foundations to deliver personalised interventions and treatments,2 the increasing ‘mainstreaming’ of genetic testing into routine practice and plans to embed whole genome sequencing in the NHS mean that the profile and importance of genomics is on the rise for many clinicians. Every human genome contains around 3–5 million genetic variants compared with the reference sequence. Genomic medicine has the capacity to revolutionise the healthcare of an individual with a rare disease or cancer by offering prompt and accurate diagnosis, risk stratification based upon genotype and the capacity for personalised treatments.
[186] Biobanking with genetics shapes precision medicine and global health ... — Modern medicine aims to provide individuals the most optimal treatment with respect to efficacy and toxicity, which can be informed by genetic and molecular data 1.In contrast to 'one-size-fits
[189] Genetic association studies - The Lancet — We review the rationale behind and discuss methods of design and analysis of genetic association studies. There are similarities between genetic association studies and classic epidemiological studies of environmental risk factors but there are also issues that are specific to studies of genetic risk factors such as the use of particular family-based designs, the need to account for different
[190] Methodologies underpinning polygenic risk scores estimation: a ... — Polygenic risk scores (PRS) have emerged as a promising tool for predicting disease risk and treatment outcomes using genomic data. Thousands of genome-wide association studies (GWAS), primarily involving populations of European ancestry, have supported the development of PRS models. However, these models have not been adequately evaluated in non-European populations, raising concerns about
[192] Distinguishing genetic correlation from causation across 52 diseases ... — This study presents a new latent causal variable (LCV) model that distinguishes between genetic correlation and causation. Applying LCV to genome-wide association summary statistics for 52 traits
[209] The Role of Statistical Genetics in Unravelling Complex Traits an — The Role of Statistical Genetics in Unravelling Complex Traits and Diseases: Methodologies, Applications, and Future Directions Kafka Twain * ... One of the fundamental challenges in statistical genetics is dealing with the vast amount of data generated by modern genomic technologies. High-dimensional data, such as sequencing studies, requires
[212] Gene set analysis of SNP data: benefits, challenges, and future directions — Yet to date, the genetic variants discovered by GWAS, based primarily on univariate analyses of individual single-nucleotide polymorphisms (SNPs), account for only a small proportion of the heritability of complex traits. 2, 3 One possible explanation for the 'missing heritability' is that the analysis strategy commonly used in GWAS, testing
[213] Center for Statistical Genetics - University of Michigan — The Center for Statistical Genetics is an interdisciplinary program which seeks to encourage research and training at the interface between human genetics and the mathematical sciences. The goals of the Center for Statistical Genetics are to: ... Encourage collaboration and technology transfer between academia and private industry;
[214] Program - Biostatistics Training Grants — The Interdisciplinary Training Program in Statistical Genetics/Genomics and Computational Biology aims to train the next generation of quantitative genomic scientists to have a strong understanding of, and commitment to, cutting-edge methodological and…
[216] Revealing third-order interactions through the integration of machine ... — As GWAS results could not thoroughly reveal the genetic background of these disorders, Genome-Wide Interaction Studies have started to gain importance. ... can address the missing heritability ... O., Rafatov, S. et al. Revealing third-order interactions through the integration of machine learning and entropy methods in genomic studies. BioData
[218] Addressing the Missing Heritability Problem With the Help of Regulatory ... — However, missing heritability is still a challenging problem. ... predict novel susceptibility loci for complex diseases based on the interpretation of regulatory features and published GWAS results with machine learning. When applied to type 2 diabetes and hypertension, the predicted susceptibility loci by FDSP were proved to be capable of
[219] Improving machine learning reproducibility in genetic association ... — Genome-wide association studies (GWAS) have been frequently critiqued for failing to explain the "missing heritability" of complex disease in terms of single-locus main effects .In addition to interrogating the contributions of rare variants, non-coding regions, structural variation, etc., a logical reactionary paradigm to embrace involves revisiting heritability estimates to
[220] Machine learning approaches to genome-wide association studies — Machine learning approaches to genome-wide association studies - ScienceDirect Machine learning approaches to genome-wide association studies Genome-wide Association Studies (GWAS) are conducted to identify single nucleotide polymorphisms (variants) associated with a phenotype within a specific population. The wide applications and abilities of Machine Learning (ML) algorithms promise to understand the effects of these variants better. The ML algorithms have been applied to the identification of significant single nucleotide polymorphisms (SNP), disease risk assessment & prediction, detection of epistatic non-linear interaction, and integrated with other omics sets. This comprehensive review has highlighted these areas of application and sheds light on the promise of innovating machine learning algorithms into the computational and statistical pipeline of genome-wide association studies. Next article in issue For all open access content, the relevant licensing terms apply.
[221] Editorial: Machine Learning in Genome-Wide Association Studies — Instead, powerful machine learning algorithms that can detect and characterize high-order interactions among multiple genetic variants are needed. The focus of this Special Topic Issue is to examine the novel design and application of machine learning algorithms in detecting interacting genetic variants for GWAS in six included articles.
[222] Recommendations for the integration of genomics into clinical practice — The introduction of diagnostic clinical genome and exome sequencing (CGES) is changing the scope of practice for clinical geneticists. Many large institutions are making a significant investment in infrastructure and technology, allowing clinicians to access CGES, especially as health-care coverage begins to extend to clinically indicated genomic sequencing-based tests.
[223] Editorial: Integration of computational genomics into clinical ... — The integration of pharmacogenomic (PGx) tests into daily clinical practice has gained significant momentum in recent years (Arbitrio et al., 2021; Mulder et al., 2021).These tests provide valuable insights into predicting and preventing adverse drug reactions (ADRs) and severe side effects, especially when utilizing a pre-emptive genotyping approach.
[234] Uncovering Missing Heritability in Rare Diseases - MDPI — Although the problem of 'missing heritability' has been mostly (read exclusively) associated with common and complex diseases in the medical research field , rare diseases also face 'missing heritability' problem despite the state-of-the-field technological advances .
[235] Missing heritability of common diseases and treatments outside the ... — What is the 'missing heritability'? Heritability is reflected by the tendency for offspring to be of similar phenotype as their parents, estimating the impact of genetics on the phenotype. Heritability can be defined as the fraction of phenotype-variability in the population that can be accounted for by the genotype.
[236] Public Health Implications of Epigenetics - PMC - National Center for ... — WE read with interest the model of epigenetic inheritance developed by Slatkin in G enetics (S latkin 2009).The problem of missing heritability is one that requires urgent consideration in many complex conditions (R amagopalan et al. 2008).However, an equally important issue to address is the public health implications of heritable epigenetic marks passed through multiple generations.
[237] Uncovering Missing Heritability in Rare Diseases - PMC — Abstract. The problem of 'missing heritability' affects both common and rare diseases hindering: discovery, diagnosis, and patient care. The 'missing heritability' concept has been mainly associated with common and complex diseases where promising modern technological advances, like genome-wide association studies (GWAS), were unable to uncover the complete genetic mechanism of the
[238] Addressing the Missing Heritability Problem With the Help of Regulatory ... — With the help of genome-wide association studies (GWASs), thousands of susceptibility loci for human complex diseases have been uncovered. However, missing heritability, which refers to the fact that published susceptibility loci could only account for limited proportion of the total heritability of complex diseases, is still a challenging problem.
[239] Solving the missing heritability problem | PLOS Genetics — The problem of missing heritability, that is to say the gap between heritability estimates from genotype data and heritability estimates from twin data, has been a source of debate for about a decade [].It might appear that the advent of whole genome sequence data on tens of thousands of people is poised to resolve the issue, but here I want to sound a note of caution: more sequence data does